{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:09:18Z","timestamp":1761102558677,"version":"3.41.0"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p><jats:italic>FAT1<\/jats:italic> is a tumor suppressor gene encoding the protocadherin FAT1, which has been found to be mutated in different types of human cancers with the highest frequency in head and neck squamous cell carcinoma (HNSCC). However, through which mechanisms mutations of <jats:italic>FAT1<\/jats:italic> lead to tumor progression is incompletely understood. Here, we report that loss of FAT1 in various tumor cells, including HNSCC cells, resulted in increased protein levels of the transcriptional regulators YAP and TAZ. This was sufficient to lead to increased expression of YAP\/TAZ target genes and to increased tumor cell proliferation. We found that elevated YAP\/TAZ activity after loss of FAT1 was due to decreased YAP\/TAZ protein degradation, which could be rescued by expression of the intracellular part of FAT1. When analyzing the interactome of the cytoplasmic part of FAT1 in tumor cells, we identified the E3 ubiquitin ligase Mind Bomb-2 (MIB2) as an interaction partner. Suppression of MIB2 expression in various tumor cells led to same effects as loss of FAT1 expression, including a decrease in YAP and TAZ ubiquitination, and degradation as well as an increase in YAP\/TAZ protein levels and expression of YAP\/TAZ target genes. Similarly, Hela cells or HNSCCs with suppressed MIB2 expression resembled FAT1 defective tumor cells showing faster proliferation <jats:italic>in vitro<\/jats:italic> as well as increased tumor growth <jats:italic>in vivo<\/jats:italic> compared to control cells. Our study identifies a mechanism by which YAP\/TAZ levels are kept low through FAT1\/MIB2-mediated protein degradation and shows that tumor progression resulting from mutation of tumor suppressor FAT1 involves loss of MIB2-dependent degradation of YAP and TAZ.<\/jats:p>","DOI":"10.1371\/journal.pone.0325535","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T17:31:43Z","timestamp":1749231103000},"page":"e0325535","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["The tumor suppressor FAT1 controls YAP\/TAZ protein degradation and tumor cell proliferation through E3 ligase MIB2"],"prefix":"10.1371","volume":"20","author":[{"given":"Rui","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Strilic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-June","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5305-2344","authenticated-orcid":true,"given":"Jingchen","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yundong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Graumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Silvio","family":"Gutkind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Wettschureck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8676-6805","authenticated-orcid":true,"given":"Stefan","family":"Offermanns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"issue":"6","key":"pone.0325535.ref001","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.3892\/ijo.2012.1669","article-title":"Function and cancer genomics of FAT family genes (review)","volume":"41","author":"M Katoh","year":"2012","journal-title":"Int J Oncol"},{"issue":"1","key":"pone.0325535.ref002","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1038\/s41467-018-04590-1","article-title":"Assembly and activation of the Hippo signalome by FAT1 tumor suppressor","volume":"9","author":"D Martin","year":"2018","journal-title":"Nat Commun"},{"issue":"6","key":"pone.0325535.ref003","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.ccell.2018.11.006","article-title":"Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4\/6 Inhibitors via the Hippo Pathway","volume":"34","author":"Z Li","year":"2018","journal-title":"Cancer Cell"},{"issue":"8","key":"pone.0325535.ref004","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nm.3878","article-title":"Genomic landscape of carcinogen-induced and genetically induced mouse skin squamous cell carcinoma","volume":"21","author":"D Nassar","year":"2015","journal-title":"Nat Med"},{"issue":"5","key":"pone.0325535.ref005","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ccell.2016.04.004","article-title":"Squamous Cell Cancers: A Unified Perspective on Biology and Genetics","volume":"29","author":"GP Dotto","year":"2016","journal-title":"Cancer Cell"},{"issue":"19","key":"pone.0325535.ref006","doi-asserted-by":"crossref","first-page":"8906","DOI":"10.18632\/oncotarget.2417","article-title":"The head and neck cancer cell oncogenome: a platform for the development of precision molecular therapies","volume":"5","author":"D Martin","year":"2014","journal-title":"Oncotarget"},{"issue":"3","key":"pone.0325535.ref007","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ng.2538","article-title":"Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation","volume":"45","author":"LGT Morris","year":"2013","journal-title":"Nat Genet"},{"issue":"7842","key":"pone.0325535.ref008","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41586-020-03046-1","article-title":"Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis","volume":"589","author":"I Pastushenko","year":"2021","journal-title":"Nature"},{"issue":"23","key":"pone.0325535.ref009","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1007\/s00018-015-1955-6","article-title":"FAT1 cadherin acts upstream of Hippo signalling through TAZ to regulate neuronal differentiation","volume":"72","author":"AF Ahmed","year":"2015","journal-title":"Cell Mol Life Sci"},{"issue":"21","key":"pone.0325535.ref010","doi-asserted-by":"crossref","first-page":"8579","DOI":"10.1073\/pnas.0811691106","article-title":"Scribble participates in Hippo signaling and is required for normal zebrafish pronephros development","volume":"106","author":"K Skouloudaki","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"pone.0325535.ref011","doi-asserted-by":"crossref","first-page":"110970","DOI":"10.1016\/j.celrep.2022.110970","article-title":"YAP1 maintains active chromatin state in head and neck squamous cell carcinomas that promotes tumorigenesis through cooperation with BRD4","volume":"39","author":"N Chen","year":"2022","journal-title":"Cell Reports"},{"issue":"2","key":"pone.0325535.ref012","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrc3876","article-title":"The emerging roles of YAP and TAZ in cancer","volume":"15","author":"T Moroishi","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"pone.0325535.ref013","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","article-title":"YAP\/TAZ at the Roots of Cancer","volume":"29","author":"F Zanconato","year":"2016","journal-title":"Cancer Cell"},{"issue":"8","key":"pone.0325535.ref014","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41568-019-0168-y","article-title":"YAP and TAZ: a signalling hub of the tumour microenvironment","volume":"19","author":"F Zanconato","year":"2019","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"pone.0325535.ref015","doi-asserted-by":"crossref","DOI":"10.1002\/bies.201900162","article-title":"YAP\/TAZ: Drivers of Tumor Growth, Metastasis, and Resistance to Therapy","volume":"42","author":"BJ Thompson","year":"2020","journal-title":"BioEssays"},{"issue":"5","key":"pone.0325535.ref016","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.trecan.2019.02.010","article-title":"YAP\/TAZ Signaling and Resistance to Cancer Therapy","volume":"5","author":"CDK Nguyen","year":"2019","journal-title":"Trends Cancer"},{"issue":"8","key":"pone.0325535.ref017","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41568-023-00579-1","article-title":"Insights into recent findings and clinical application of YAP and TAZ in cancer","volume":"23","author":"JM Franklin","year":"2023","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"pone.0325535.ref018","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.cmet.2018.07.010","article-title":"Interplay between YAP\/TAZ and Metabolism","volume":"28","author":"JH Koo","year":"2018","journal-title":"Cell Metab"},{"key":"pone.0325535.ref019","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1146\/annurev-biochem-013118-111829","article-title":"The Hippo Pathway: Biology and Pathophysiology","volume":"88","author":"S Ma","year":"2019","journal-title":"Annu Rev Biochem"},{"issue":"12","key":"pone.0325535.ref020","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nrm.2017.87","article-title":"Mechanobiology of YAP and TAZ in physiology and disease","volume":"18","author":"T Panciera","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"pone.0325535.ref021","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/s41556-018-0142-z","article-title":"YAP\/TAZ upstream signals and downstream responses","volume":"20","author":"A Totaro","year":"2018","journal-title":"Nat Cell Biol"},{"issue":"11","key":"pone.0325535.ref022","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.tibs.2017.09.003","article-title":"Regulation of the Hippo Pathway Transcription Factor TEAD","volume":"42","author":"KC Lin","year":"2017","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"pone.0325535.ref023","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.devcel.2019.06.003","article-title":"The Hippo Signaling Pathway in Development and Disease","volume":"50","author":"Y Zheng","year":"2019","journal-title":"Dev Cell"},{"issue":"3","key":"pone.0325535.ref024","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1158\/0008-5472.CAN-08-2997","article-title":"Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein","volume":"69","author":"B Zhao","year":"2009","journal-title":"Cancer Res"},{"issue":"4","key":"pone.0325535.ref025","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.devcel.2010.09.011","article-title":"The Hippo Signaling Pathway in Development and Cancer","volume":"19","author":"D Pan","year":"2010","journal-title":"Developmental Cell"},{"issue":"1","key":"pone.0325535.ref026","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1038\/s41467-023-37671-x","article-title":"Endothelial FAT1 inhibits angiogenesis by controlling YAP\/TAZ protein degradation via E3 ligase MIB2","volume":"14","author":"R Li","year":"2023","journal-title":"Nat Commun"},{"issue":"48","key":"pone.0325535.ref027","doi-asserted-by":"crossref","first-page":"37159","DOI":"10.1074\/jbc.M110.152942","article-title":"The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase","volume":"285","author":"C-Y Liu","year":"2010","journal-title":"J Biol Chem"},{"issue":"1","key":"pone.0325535.ref028","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1101\/gad.1843810","article-title":"A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF\u03b2-TRCP","volume":"24","author":"B Zhao","year":"2010","journal-title":"Genes Dev"},{"issue":"1","key":"pone.0325535.ref029","article-title":"Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma","volume":"13","author":"K Tu","year":"2014","journal-title":"Mol Cancer"},{"issue":"3","key":"pone.0325535.ref030","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41389-020-0220-5","article-title":"Regulation of Hippo signaling and triple negative breast cancer progression by an ubiquitin ligase RNF187","volume":"9","author":"Z Wang","year":"2020","journal-title":"Oncogenesis"},{"issue":"3","key":"pone.0325535.ref031","article-title":"PD-L1 translocation to the plasma membrane enables tumor immune evasion through MIB2 ubiquitination","volume":"133","author":"X Yu","year":"2023","journal-title":"J Clin Invest"},{"issue":"53","key":"pone.0325535.ref032","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1038\/sj.onc.1209688","article-title":"A ubiquitin ligase, skeletrophin, is a negative regulator of melanoma invasion","volume":"25","author":"T Takeuchi","year":"2006","journal-title":"Oncogene"},{"issue":"11","key":"pone.0325535.ref033","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/dvg.20349","article-title":"Targeted disruption of Mib2 causes exencephaly with a variable penetrance","volume":"45","author":"JI Wu","year":"2007","journal-title":"Genesis"},{"issue":"23","key":"pone.0325535.ref034","doi-asserted-by":"crossref","first-page":"22335","DOI":"10.1074\/jbc.M501631200","article-title":"Mind bomb-2 is an E3 ligase for Notch ligand","volume":"280","author":"B-K Koo","year":"2005","journal-title":"J Biol Chem"},{"issue":"2","key":"pone.0325535.ref035","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41573-020-00091-3","article-title":"Targeting Notch in oncology: the path forward","volume":"20","author":"S Majumder","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"pone.0325535.ref036","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrc.2016.145","article-title":"Notch as a tumour suppressor","volume":"17","author":"CS Nowell","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"24","key":"pone.0325535.ref037","doi-asserted-by":"crossref","first-page":"6219","DOI":"10.3390\/cancers13246219","article-title":"Shooting at Moving and Hidden Targets-Tumour Cell Plasticity and the Notch Signalling Pathway in Head and Neck Squamous Cell Carcinomas","volume":"13","author":"J Ka\u0142afut","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"6046","key":"pone.0325535.ref038","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1126\/science.1206923","article-title":"Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1","volume":"333","author":"N Agrawal","year":"2011","journal-title":"Science"},{"issue":"6046","key":"pone.0325535.ref039","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.1208130","article-title":"The Mutational Landscape of Head and Neck Squamous Cell Carcinoma","volume":"333","author":"N Stransky","year":"2011","journal-title":"Science"},{"issue":"4","key":"pone.0325535.ref040","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3390\/cancers10040115","article-title":"YAP\/TAZ Activation as a Target for Treating Metastatic Cancer","volume":"10","author":"JSA Warren","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"1","key":"pone.0325535.ref041","article-title":"Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer","volume":"12","author":"Z Wang","year":"2021","journal-title":"Nat Commun"},{"issue":"8","key":"pone.0325535.ref042","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1172\/JCI81067","article-title":"P2Y\u2082 and Gq\/G\u2081\u2081 control blood pressure by mediating endothelial mechanotransduction","volume":"125","author":"S Wang","year":"2015","journal-title":"J Clin Invest"},{"issue":"1","key":"pone.0325535.ref043","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13148-019-0774-2","article-title":"Epigenetic therapy of novel tumour suppressor ZAR1 and its cancer biomarker function","volume":"11","author":"V Deutschmeyer","year":"2019","journal-title":"Clin Epigenetics"},{"issue":"8","key":"pone.0325535.ref044","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1074\/mcp.TIR119.001505","article-title":"MARMoSET - Extracting Publication-ready Mass Spectrometry Metadata from RAW Files","volume":"18","author":"M Kiweler","year":"2019","journal-title":"Mol Cell Proteomics"},{"issue":"4","key":"pone.0325535.ref045","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1021\/pr101065j","article-title":"Andromeda: a peptide search engine integrated into the MaxQuant environment","volume":"10","author":"J Cox","year":"2011","journal-title":"J Proteome Res"},{"issue":"12","key":"pone.0325535.ref046","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nbt.1511","article-title":"MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification","volume":"26","author":"J Cox","year":"2008","journal-title":"Nat Biotechnol"},{"issue":"9","key":"pone.0325535.ref047","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1074\/mcp.M113.031591","article-title":"Accurate Proteome-wide Label-free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ","volume":"13","author":"J Cox","year":"2014","journal-title":"Molecular & Cellular Proteomics"},{"key":"pone.0325535.ref048","author":"A Bhagwat","year":"2021"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0325535","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T17:31:55Z","timestamp":1749231115000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0325535"}},"subtitle":[],"editor":[{"given":"Khushboo","family":"Irshad","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":48,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0325535","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]}}}